ReviewBlood2025

Precision medicine for high-risk gene fusions in pediatric AML: a focus on KMT2A, NUP98, and GLIS2 rearrangements.

Grace Egan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.